Table of Contents page: European Journal of Cancer

Property	Value
Status
Version
Ad File
Disable Ads Flag
Environment
Moat Init
Moat Ready
Contextual Ready
Contextual URL
Contextual Initial Segments
Contextual Used Segments
AdUnit
SubAdUnit
Custom Targeting
Ad Events
Invalid Ad Sizes

Association between endocrine therapy and cognitive decline in older women with early breast cancer: Findings from the prospective CLIMB study

Joosje C. Baltussen,
Marloes G.M. Derks,
Annelieke A. Lemij,
...
Simon P. Mooijaart,
Johanneke E.A. Portielje,
Gerrit-Jan Liefers

Published online: February 16, 2023

p1-10

Open Access

Clinical outcomes of adjuvant taxane plus anthracycline versus taxane-based chemotherapy regimens in older adults with node-positive, triple-negative breast cancer: A SEER–Medicare study

Savannah Roy,
Stephanie Lakritz,
Anna R. Schreiber,
...
Lavanya Kondapalli,
Cathy J. Bradley,
Jennifer R. Diamond

Published online: February 27, 2023

p69-82

Evolution of biological features of invasive lobular breast cancer: Comparison between primary tumour and metastases

Pamela Trillo,
Josè Sandoval,
Dario Trapani,
...
Angela Esposito,
Carmen Criscitiello,
Giuseppe Curigliano

Published online: March 07, 2023

p119-130

Spatial immunophenotyping of the tumour microenvironment in non–small cell lung cancer

Max Backman,
Carina Strell,
Amanda Lindberg,
...
Karin Leandersson,
Artur Mezheyeuski,
Patrick Micke

Published online: February 24, 2023

p40-52

Open Access

Phase 2 study of osimertinib in combination with platinum and pemetrexed in patients with previously untreated EGFR-mutated advanced non-squamous non-small cell lung cancer: The OPAL Study

Ryota Saito,
Shunichi Sugawara,
Ryo Ko,
...
Kentaro Tanaka,
Kenji Sugio,
Kunihiko Kobayashi

Published online: March 01, 2023

p83-93

Open Access

Definition, diagnosis and treatment of oligometastatic oesophagogastric cancer: A Delphi consensus study in Europe

Tiuri E. Kroese,
Hanneke W.M. van Laarhoven,
Sebastian F. Schoppman,
...
Richard van Hillegersberg,
Peter S.N. van Rossum
On behalf of the OMEC collaborators

Published online: February 23, 2023

p28-39

Open Access

Risk and location of distant metastases in patients with locally advanced rectal cancer after total neoadjuvant treatment or chemoradiotherapy in the RAPIDO trial

Renu R. Bahadoer,
Geke A.P. Hospers,
Corrie A.M. Marijnen,
...
Bengt Glimelius,
Cornelis J.H. van de Velde
collaborative investigators

Published online: March 07, 2023

p139-149

Open Access

Impact of concurrent tumour events on the prostate cancer outcomes of germline BRCA2 mutation carriers

Rebeca Lozano,
Elena Castro,
Fernando Lopez-Campos,
...
José Rubio-Briones,
Shahneen Sandhu,
David Olmos

Published online: March 03, 2023

p105-118

A federated approach to identify women with early-stage cervical cancer at low risk of lymph node metastases

Hans H.B. Wenzel,
Anna N. Hardie,
Arturo Moncada-Torres,
...
Algirdas Markauskas,
Katrine Fuglsang,
Tine H. Schnack

Published online: February 25, 2023

p61-68

Survival outcomes, prognostic factors, and effect of adjuvant radiotherapy and prophylactic neck dissection in salivary acinic cell carcinoma: A prospective multicenter REFCOR study of 187 patients

Florian Chatelet,
François Régis Ferrand,
Sarah Atallah,
...
Philippe Herman,
Benjamin Verillaud
REFCOR members

Published online: March 01, 2023

p11-27

Observational study investigating the level of support from a convolutional neural network in face and scalp lesions deemed diagnostically ‘unclear’ by dermatologists

Katharina S. Kommoss,
Julia K. Winkler,
Christine Mueller-Christmann,
...
Alexander Enk,
Albert Rosenberger,
Holger A. Haenssle

Published online: March 03, 2023

p53-60

Surgical outcomes of lymph node dissections for stage III melanoma after neoadjuvant systemic therapy are not inferior to upfront surgery

Lisanne P. Zijlker,
Stijn J.C. van der Burg,
Christian U. Blank,
...
Michel W.M.J. Wouters,
Winan J. van Houdt,
Alexander C.J. van Akkooi

Published online: March 07, 2023

p131-138

Anthropometric indicators of adiposity and risk of primary liver cancer: A systematic review and dose–response meta-analysis

Lun-Jie Yan,
Long-Shan Yang,
Yu-Chuan Yan,
...
Dong-Xu Wang,
Zhao-Ru Dong,
Tao Li

Published online: March 07, 2023

p150-163

CT radiomics compared to a clinical model for predicting checkpoint inhibitor treatment outcomes in patients with advanced melanoma

Laurens S. ter Maat,
Isabella A.J. van Duin,
Sjoerd G. Elias,
...
Pim A. de Jong,
Karijn P.M. Suijkerbuijk,
Mitko Veta

Published online: February 24, 2023

p167-177

Open Access

Anthracycline-induced cardiotoxicity — are we about to clear this hurdle?

Wolfram C.M. Dempke,
Rafal Zielinski,
Christina Winkler,
Sandra Silberman,
Susanne Reuther,
Waldemar Priebe

Published online: February 24, 2023

p94-104

Open Access

Ineligible for transplant, but eligible for intensive quadruplet therapy—The value of ‘add-on’ trials for vulnerable patient populations

Ghulam Rehman Mohyuddin,
Aaron M. Goodman

Published online: March 28, 2023

p164-166

May 2023

Volume 185, In Progress

Breast cancer

Association between endocrine therapy and cognitive decline in older women with early breast cancer: Findings from the prospective CLIMB study

Clinical outcomes of adjuvant taxane plus anthracycline versus taxane-based chemotherapy regimens in older adults with node-positive, triple-negative breast cancer: A SEER–Medicare study

Evolution of biological features of invasive lobular breast cancer: Comparison between primary tumour and metastases

Lung cancer

Spatial immunophenotyping of the tumour microenvironment in non–small cell lung cancer

Phase 2 study of osimertinib in combination with platinum and pemetrexed in patients with previously untreated EGFR-mutated advanced non-squamous non-small cell lung cancer: The OPAL Study

Gastrointestinal oncology

Definition, diagnosis and treatment of oligometastatic oesophagogastric cancer: A Delphi consensus study in Europe

Risk and location of distant metastases in patients with locally advanced rectal cancer after total neoadjuvant treatment or chemoradiotherapy in the RAPIDO trial

Urologic oncology

Impact of concurrent tumour events on the prostate cancer outcomes of germline BRCA2 mutation carriers

Gynecologic oncology

A federated approach to identify women with early-stage cervical cancer at low risk of lymph node metastases

Head and neck oncology

Survival outcomes, prognostic factors, and effect of adjuvant radiotherapy and prophylactic neck dissection in salivary acinic cell carcinoma: A prospective multicenter REFCOR study of 187 patients

Melanoma and skin cancers

Observational study investigating the level of support from a convolutional neural network in face and scalp lesions deemed diagnostically ‘unclear’ by dermatologists

Surgical outcomes of lymph node dissections for stage III melanoma after neoadjuvant systemic therapy are not inferior to upfront surgery

Epidemiology and prevention

Anthropometric indicators of adiposity and risk of primary liver cancer: A systematic review and dose–response meta-analysis

Digital Oncology

CT radiomics compared to a clinical model for predicting checkpoint inhibitor treatment outcomes in patients with advanced melanoma

Other

Anthracycline-induced cardiotoxicity — are we about to clear this hurdle?

Correspondence

Ineligible for transplant, but eligible for intensive quadruplet therapy—The value of ‘add-on’ trials for vulnerable patient populations